4,593
Views
2
CrossRef citations to date
0
Altmetric
Original Investigations

Effects of testosterone suppression on desire, hypersexuality, and sexual interest in children in men with pedophilic disorder

ORCID Icon, , &
Pages 560-571 | Received 29 Mar 2021, Accepted 02 Dec 2021, Published online: 10 Jan 2022

Figures & data

Table 1. Demographic characteristics at baseline.

Figure 1. (A,B) Box-plot and individual trajectories of Sexual Desire Inventory and Hypersexual Behaviour Inventory scores among participants with paedophilic disorder treated with degarelix and placebo. Abbreviations: SDI: Sexual Desire Inventory (range 12–104); HBI: Hypersexual Behaviour Inventory (range 19–95). Notches of the box-plots can be used to compare groups; notch = median +/- 1.58 * IQR/sqrt(n).

Figure 1. (A,B) Box-plot and individual trajectories of Sexual Desire Inventory and Hypersexual Behaviour Inventory scores among participants with paedophilic disorder treated with degarelix and placebo. Abbreviations: SDI: Sexual Desire Inventory (range 12–104); HBI: Hypersexual Behaviour Inventory (range 19–95). Notches of the box-plots can be used to compare groups; notch = median +/- 1.58 * IQR/sqrt(n).

Figure 2. Effect sizes (Cohen's d) on sexual measures in participants with paedophilic disorder treated with degarelix or placebo. P: placebo; D: degarelix. P week 2, P week 10, D week 2 and D week 10 depicts within-group effects of decrease compared to baseline. D vs. P week 2 and D vs. P week 10 are between-group effects of the decrease from baseline.

Figure 2. Effect sizes (Cohen's d) on sexual measures in participants with paedophilic disorder treated with degarelix or placebo. P: placebo; D: degarelix. P week 2, P week 10, D week 2 and D week 10 depicts within-group effects of decrease compared to baseline. D vs. P week 2 and D vs. P week 10 are between-group effects of the decrease from baseline.

Table 2. Exploratory analyses of putative modifiers of effects from degarelix at ten weeks.